Promises and challenges of pneumococcal conjugate vaccines for the developing world

Clin Infect Dis. 2006 Sep 15;43(6):680-2. doi: 10.1086/506945. Epub 2006 Aug 4.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Carrier State
  • Child, Preschool
  • Developing Countries*
  • Drug Resistance, Bacterial
  • Gambia / epidemiology
  • Humans
  • Infant
  • Infant, Newborn
  • Middle Aged
  • Pneumococcal Infections / microbiology
  • Pneumococcal Infections / prevention & control*
  • Pneumococcal Vaccines* / economics
  • Risk Factors
  • Serotyping
  • Streptococcus pneumoniae / classification
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / isolation & purification
  • Vaccines, Conjugate

Substances

  • Anti-Bacterial Agents
  • Pneumococcal Vaccines
  • Vaccines, Conjugate